Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives
Katrina Weston‐Green
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14

Showing 14 citing articles:

Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
Paulina Glajzner, Agnieszka Bernat, Magdalena Jasińska-Stroschein
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Direct Effects of Antipsychotics on Potassium Channels
Wenwen Zhuang, Seo‐Yeong Mun, Won Sun Park
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151344-151344
Closed Access
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
Katherine R. H. Mortimer, Mohammed Zia Ul Haq Katshu, Lisa Chakrabarti
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Generation of dual-target compounds using a transformer chemical language model
Sanjana Srinivasan, Jürgen Bajorath
Cell Reports Physical Science (2024), pp. 102255-102255
Open Access | Times Cited: 2
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal
Brian Dean
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 12, pp. 1113-1121
Closed Access | Times Cited: 6
Generation of Dual-Target Compounds Using a Transformer Chemical Language Model
Sanjana Srinivasan, Jürgen Bajorath
(2024)
Open Access | Times Cited: 2
Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
Amrit Sandhu, Elnaz Naderi, Morenika Wijninga, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1354-1354
Open Access | Times Cited: 4
Origins and progression of the polypharmacology concept in drug discovery
Jürgen Bajorath
Artificial Intelligence in the Life Sciences (2024) Vol. 5, pp. 100094-100094
Open Access | Times Cited: 1
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
Priyanka Moondra, Joohi Jimenez‐Shahed
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 9, pp. 849-863
Closed Access | Times Cited: 1
Identification of schizophrenia symptom-related gene modules by postmortem brain transcriptome analysis
Kazusa Miyahara, Mizuki Hino, Risa Shishido, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
TMS in Schizophrenia: Potential Mechanistic Insights via Resting-State Network Analyses
Andrew van der Vaart
Current Behavioral Neuroscience Reports (2023) Vol. 10, Iss. 3, pp. 58-63
Closed Access | Times Cited: 3
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice
Andrés Rodríguez-Vega, Ana Carolina Dutra-Tavares, Thainá P. Souza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14634-14634
Open Access | Times Cited: 2
Pregnancy as a challenge for a patient with schizophrenia
Julia Bogucka, Anna Brzyska, Małgorzata Bojarska, et al.
Current Problems of Psychiatry (2024) Vol. 25, pp. 156-164
Open Access
Introduction
Jürgen Bajorath
(2024), pp. 1-7
Closed Access
Page 1

Scroll to top